SCHEMBL31264367

SCHEMBL31264367

CCCCC/C=C\C/C=C\CCCC(=O)OCC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.78
PGR P06401 1/20 0.78
ADORA3 P0DMS8 1/20 0.78
PTGS2 P35354 1/20 0.78
PDE4D Q08499 1/20 0.78
MGLL Q99685 1/20 0.74
ALDH1A1 P00352 4/20 0.73
CYP3A4 P08684 2/20 0.73
ALOX15 P16050 2/20 0.73
HSD17B10 Q99714 2/20 0.73
TDP1 Q9NUW8 2/20 0.73
TSHR P16473 1/20 0.73
CNR1 P21554 4/20 0.72
MAPT P10636 3/20 0.72
THRB P10828 1/20 0.72
FAAH O00519 3/20 0.67
PPARG P37231 2/20 0.64
HPGD P15428 2/20 0.64
KDM4E B2RXH2 1/20 0.64
MEN1 O00255 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24209 1.00 NR1I2 (0.78) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL4807962 1.00 NR1I2 (0.78) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL24208 1.00 NR1I2 (0.78) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL20582488 1.00 NR1I2 (0.78) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL20582487 1.00 NR1I2 (0.78) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL6810935 0.98 ALDH1A1 (0.77) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL7796369 0.98 ALDH1A1 (0.77) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL5738380 0.98 ALDH1A1 (0.77) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL5738375 0.98 ALDH1A1 (0.77) NR1I2PGRADORA3PTGS2PDE4D
SCHEMBL29655825 0.98 NR1I2 (0.76) NR1I2PGRADORA3PTGS2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720051-A1 IONIZABLE LIPIDS Bristol-Myers Squibb Company (US) 2026-04-08 EP disclosed
EP-3335140-B1 SYSTEMS, APPARATUS, AND METHODS FOR ANALYZING AND PREDICTING CELLULAR PATHWAYS MASSACHUSETTS INST TECHNOLOGY (US) 2025-02-19 EP disclosed
US-20240390284-A1 IONIZABLE LIPIDS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-11-28 US disclosed
WO-2024243480-A1 IONIZABLE LIPIDS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240390284-A1 IONIZABLE LIPIDS NPC1L1, ABCB4, NPC1 NR1I2 2550/4885PGR 1267/4885ADORA3 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.